US2021171507A1PendingUtilityA1

Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors

Assignee: GENZYME CORPPriority: Jul 16, 2001Filed: Jul 23, 2020Published: Jun 10, 2021
Est. expiryJul 16, 2021(expired)· nominal 20-yr term from priority
A61P 35/00C07D 295/185A61P 27/02A61P 25/28A61P 1/16A61K 31/4025C07D 405/06C07D 319/18C07D 498/04A61P 43/00A61P 17/02A61P 3/00A61P 7/06
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose:N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.

Claims

exact text as granted — not AI-modified
1 - 23 . (canceled) 
     
     
         24 . A method of preparing a compound of formula (2) 
       
         
           
           
               
               
           
         
       
       said method comprising reacting a compound of formula (1) 
       
         
           
           
               
               
           
         
       
       with pyrrolidine, followed by hydrolysis. 
     
     
         25 . The method of  claim 24 , wherein the hydrolysis is carried out using methanol as solvent. 
     
     
         26 . The method of  claim 24 , wherein the compound of formula (1) is prepared by reacting (5S)-5-phenylmorpholin-2-one with 1,4-benzodioxan-6-carboxaldehyde. 
     
     
         27 . The method of  claim 26 , wherein (5S)-5-phenylmorpholin-2-one is prepared by reacting a compound of formula (i) 
       
         
           
           
               
               
           
         
       
       with a compound of formula (ii) 
       
         
           
           
               
               
           
         
       
     
     
         28 . The method of  claim 24 , further comprising reducing the compound of formula (2) to form a compound of formula (3) 
       
         
           
           
               
               
           
         
       
     
     
         29 . The method of  claim 28 , wherein the reduction is carried out using lithium aluminum hydride. 
     
     
         30 . A method of preparing a compound of formula (3) 
       
         
           
           
               
               
           
         
       
       said method comprising reducing a compound of formula (2) 
       
         
           
           
               
               
           
         
       
     
     
         31 . The method of  claim 30 , wherein the reduction is carried out using lithium aluminum hydride. 
     
     
         32 . The method of  claim 30 , wherein the compound of formula (2) is prepared by reacting a compound of formula (1) 
       
         
           
           
               
               
           
         
       
       with pyrrolidine, followed by hydrolysis. 
     
     
         33 . The method of  claim 32 , wherein the hydrolysis is carried out using methanol as solvent. 
     
     
         34 . The method of  claim 32 , wherein the compound of formula (1) is prepared by reacting (5S)-5-phenylmorpholin-2-one with 1,4-benzodioxan-6-carboxaldehyde. 
     
     
         35 . The method of  claim 34 , wherein (5S)-5-phenylmorpholin-2-one is prepared by reacting a compound of formula (i) 
       
         
           
           
               
               
           
         
       
       with a compound of formula (ii)

Join the waitlist — get patent alerts

Track US2021171507A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.